Antibodies: A Double Leg Takedown Against COVID-19.
作者信息
Mondelli Mario U
机构信息
Division of Clinical Immunology and Infectious Diseases, Department of Medicine, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy.
出版信息
J Infect Dis. 2022 May 16;225(10):1685-1687. doi: 10.1093/infdis/jiac061.
Abstract
摘要
相似文献
1
Antibodies: A Double Leg Takedown Against COVID-19.抗体：对抗新冠病毒的双重攻势
J Infect Dis. 2022 May 16;225(10):1685-1687. doi: 10.1093/infdis/jiac061.
2
Natural Killer Cell-Mediated Antibody-Dependent Cellular Cytotoxicity Against SARS-CoV-2 After Natural Infection Is More Potent Than After Vaccination.自然杀伤细胞介导的针对 SARS-CoV-2 的抗体依赖的细胞细胞毒性在自然感染后比在接种疫苗后更强。
J Infect Dis. 2022 May 16;225(10):1688-1693. doi: 10.1093/infdis/jiac060.
3
NK cell frequencies, function and correlates to vaccine outcome in BNT162b2 mRNA anti-SARS-CoV-2 vaccinated healthy and immunocompromised individuals.BNT162b2 mRNA 抗 SARS-CoV-2 疫苗接种健康和免疫功能低下个体的 NK 细胞频率、功能及其与疫苗结果的相关性。
Mol Med. 2022 Feb 8;28(1):20. doi: 10.1186/s10020-022-00443-2.
4
Long-Term Humoral Immune Response against SARS-CoV-2 after Natural Infection and Subsequent Vaccination According to WHO International Binding Antibody Units (BAU/mL).根据世界卫生组织国际结合抗体单位（BAU/mL），自然感染和随后接种疫苗后对 SARS-CoV-2 的长期体液免疫反应。
Viruses. 2021 Nov 23;13(12):2336. doi: 10.3390/v13122336.
5
Antibodies against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) in individuals with and without COVID-19 vaccination: A method comparison of two different commercially available serological assays from the same manufacturer.针对 COVID-19 疫苗接种者和未接种者的严重急性呼吸综合征冠状病毒 2 型（SARS-CoV-2）抗体：来自同一制造商的两种不同商业可用血清学检测方法的比较方法。
Clin Chim Acta. 2021 Jul;518:9-16. doi: 10.1016/j.cca.2021.03.007. Epub 2021 Mar 17.
6
Can Natural Killer Cells Be a Principal Player in Anti-SARS-CoV-2 Immunity?自然杀伤细胞能否成为抗SARS-CoV-2免疫的主要参与者？
Front Immunol. 2020 Dec 7;11:586765. doi: 10.3389/fimmu.2020.586765. eCollection 2020.
7
Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial.新型冠状病毒 ARCoV mRNA 疫苗在中国成年人中的安全性和免疫原性：一项随机、双盲、安慰剂对照、1 期临床试验。
Lancet Microbe. 2022 Mar;3(3):e193-e202. doi: 10.1016/S2666-5247(21)00280-9. Epub 2022 Jan 24.
8
The Levels of SARS-CoV-2 Specific Antibodies in Human Milk Following Vaccination.人乳中 SARS-CoV-2 特异性抗体水平的研究。
J Hum Lact. 2021 Aug;37(3):477-484. doi: 10.1177/08903344211027112. Epub 2021 Jun 27.
9
Taking on SARS-CoV-2.迎战 SARS-CoV-2。
Elife. 2022 Jun 28;11:e80552. doi: 10.7554/eLife.80552.
10
Neutralizing antibody responses 300 days after SARS-CoV-2 infection and induction of high antibody titers after vaccination.SARS-CoV-2 感染 300 天后的中和抗体反应和接种疫苗后高抗体滴度的诱导。
Eur J Immunol. 2022 May;52(5):810-815. doi: 10.1002/eji.202149758. Epub 2022 Mar 14.
本文引用的文献
1
Natural Killer Cell-Mediated Antibody-Dependent Cellular Cytotoxicity Against SARS-CoV-2 After Natural Infection Is More Potent Than After Vaccination.自然杀伤细胞介导的针对 SARS-CoV-2 的抗体依赖的细胞细胞毒性在自然感染后比在接种疫苗后更强。
J Infect Dis. 2022 May 16;225(10):1688-1693. doi: 10.1093/infdis/jiac060.
2
SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron.SARS-CoV-2 疫苗接种可诱导能够交叉识别 Alpha 到奥密克戎变体的免疫 T 细胞记忆。
Cell. 2022 Mar 3;185(5):847-859.e11. doi: 10.1016/j.cell.2022.01.015. Epub 2022 Jan 24.
3
A Fc-enhanced NTD-binding non-neutralizing antibody delays virus spread and synergizes with a nAb to protect mice from lethal SARS-CoV-2 infection.一种Fc增强的NTD结合非中和抗体可延缓病毒传播，并与一种中和抗体协同作用，保护小鼠免受致命的SARS-CoV-2感染。
Cell Rep. 2022 Feb 15;38(7):110368. doi: 10.1016/j.celrep.2022.110368. Epub 2022 Jan 25.
4
Innate immunity: the first line of defense against SARS-CoV-2.先天免疫：抵御 SARS-CoV-2 的第一道防线。
Nat Immunol. 2022 Feb;23(2):165-176. doi: 10.1038/s41590-021-01091-0. Epub 2022 Feb 1.
5
Generation of High Quality Memory B Cells.产生高质量的记忆 B 细胞。
Front Immunol. 2022 Jan 12;12:825813. doi: 10.3389/fimmu.2021.825813. eCollection 2021.
6
SARS-CoV-2 Spike Expression at the Surface of Infected Primary Human Airway Epithelial Cells.SARS-CoV-2 刺突蛋白在感染的原代人呼吸道上皮细胞表面的表达。
Viruses. 2021 Dec 21;14(1):5. doi: 10.3390/v14010005.
7
High Frequencies of Functional Virus-Specific CD4 T Cells in SARS-CoV-2 Subjects With Olfactory and Taste Disorders.嗅觉和味觉障碍的 SARS-CoV-2 患者中功能性病毒特异性 CD4 T 细胞的高频出现。
Front Immunol. 2021 Nov 10;12:748881. doi: 10.3389/fimmu.2021.748881. eCollection 2021.
8
Characterizing Long COVID: Deep Phenotype of a Complex Condition.长新冠的特征：复杂病症的深度表型。
EBioMedicine. 2021 Dec;74:103722. doi: 10.1016/j.ebiom.2021.103722. Epub 2021 Nov 25.
9
Sterilizing Immunity against COVID-19: Developing Helper T cells I and II activating vaccines is imperative.对 COVID-19 进行免疫消毒：开发辅助性 T 细胞 I 和 II 激活疫苗是当务之急。
Biomed Pharmacother. 2021 Dec;144:112282. doi: 10.1016/j.biopha.2021.112282. Epub 2021 Oct 2.
10
A new flow cytometry assay to measure antibody-dependent cellular cytotoxicity against SARS-CoV-2 Spike-expressing cells.一种新的流式细胞术检测方法，用于测量针对表达 SARS-CoV-2 刺突蛋白的细胞的抗体依赖性细胞细胞毒性。
STAR Protoc. 2021 Dec 17;2(4):100851. doi: 10.1016/j.xpro.2021.100851. Epub 2021 Sep 13.
Zotero 插件